Press release
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
- In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corporate Update Conference Call
About this update from Siga Technologies Inc.
[{"type":"text","content":"- In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2023. “SIGA’s second quarter financial results reflect the continuation of international sales activity that began in mid 2022,” said Phil Gomez, CEO of SIGA. “Importantly, revenues for the first half of 2023 represent only a small percentage of revenues expected for 2023. In the second half of 2023, the Company expects to generate approximately $113 million of revenues from deliveries of oral TPOXX to the U.S. strategic national stockpile and to generate between $30 million and $45 million of revenues from a broad cross-section of domestic and international deliveries, including deliveries of oral TPOXX to the Department of Defense, IV TPOXX to the U.S. strategic national stockpile and oral TPOXX to international customers. Such revenues in the second half of the year, when combined with the financial results of the first half of 2023, are expected to generate full year 2023 pre-tax operating income of between $90 million and $100 million. We are pleased that we are able to consistently meet demand for oral TPOXX, which is driving substantial and increasingly diversified global revenue opportunities at SIGA.” Summary Financial Results($ in millions, except per share amounts) Second Quarter 2023 in comparison to Second Quarter 2022 Three Months Ended June 30, 2023 Three Months Ended June 30, 2022Total RevenuesOperating (Loss) Income (1)(Loss) Income before Income Taxes (1)Net (Loss) IncomeDiluted (Loss) Income per Share$5.9($4.6)($3.4)($2.9)($0.04) per share $16.7$3.1$3.2$2.0$0.03 per share Six Months Ended June 30, 2023 in comparison to Six Months Ended June 30, 2022 Six Months Ended June 30, 2023 Six Months Ended June 30, 2022Total RevenuesOperating (Loss) Income (1)(Loss) Income before Income Taxes (1)Net (Loss) Income Diluted (Loss) Income per Share$14.2($6.7)($4.7)($3.8)($0.05) per share $27.2$1.6$2.1$1.7$0.02 per share (1) Operating Income / (Loss) excludes, and Income / (Loss) before Income Taxes includes, interest income, and adjustment...